Analysis of Liquidity Ratios
Quarterly Data
Liquidity ratios measure the company ability to meet its short-term obligations.
Liquidity Ratios (Summary)
AmerisourceBergen Corp., liquidity ratios (quarterly data)
Based on: 10-Q (reporting date: 2023-06-30), 10-Q (reporting date: 2023-03-31), 10-Q (reporting date: 2022-12-31), 10-K (reporting date: 2022-09-30), 10-Q (reporting date: 2022-06-30), 10-Q (reporting date: 2022-03-31), 10-Q (reporting date: 2021-12-31), 10-K (reporting date: 2021-09-30), 10-Q (reporting date: 2021-06-30), 10-Q (reporting date: 2021-03-31), 10-Q (reporting date: 2020-12-31), 10-K (reporting date: 2020-09-30), 10-Q (reporting date: 2020-06-30), 10-Q (reporting date: 2020-03-31), 10-Q (reporting date: 2019-12-31), 10-K (reporting date: 2019-09-30), 10-Q (reporting date: 2019-06-30), 10-Q (reporting date: 2019-03-31), 10-Q (reporting date: 2018-12-31), 10-K (reporting date: 2018-09-30), 10-Q (reporting date: 2018-06-30), 10-Q (reporting date: 2018-03-31), 10-Q (reporting date: 2017-12-31), 10-K (reporting date: 2017-09-30), 10-Q (reporting date: 2017-06-30), 10-Q (reporting date: 2017-03-31), 10-Q (reporting date: 2016-12-31).
| Liquidity ratio | Description | The company |
|---|---|---|
| Current ratio | A liquidity ratio calculated as current assets divided by current liabilities. | AmerisourceBergen Corp. current ratio deteriorated from Q1 2023 to Q2 2023 and from Q2 2023 to Q3 2023. |
| Quick ratio | A liquidity ratio calculated as (cash plus short-term marketable investments plus receivables) divided by current liabilities. | AmerisourceBergen Corp. quick ratio improved from Q1 2023 to Q2 2023 and from Q2 2023 to Q3 2023. |
| Cash ratio | A liquidity ratio calculated as (cash plus short-term marketable investments) divided by current liabilities. | AmerisourceBergen Corp. cash ratio deteriorated from Q1 2023 to Q2 2023 and from Q2 2023 to Q3 2023. |
Current Ratio
AmerisourceBergen Corp., current ratio calculation (quarterly data)
| Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selected Financial Data (US$ in thousands) | |||||||||||||||||||||||||||||||||||
| Current assets | 40,986,584) | 39,989,641) | 40,708,125) | 39,589,758) | 39,744,526) | 39,409,740) | 39,378,885) | 38,802,609) | 37,259,766) | 35,469,149) | 34,700,221) | 33,055,702) | 29,918,572) | 31,180,650) | 28,954,816) | 28,132,054) | 27,401,778) | 27,622,183) | 27,476,207) | 25,894,372) | 26,404,401) | 26,397,211) | 25,296,432) | 24,303,299) | 23,677,224) | 23,493,921) | 23,078,756) | ||||||||
| Current liabilities | 46,783,211) | 45,071,097) | 44,760,623) | 43,477,955) | 43,154,310) | 42,797,581) | 41,613,605) | 41,358,641) | 39,589,838) | 32,996,446) | 35,044,451) | 33,853,077) | 30,631,571) | 32,111,790) | 30,630,456) | 29,581,294) | 28,788,871) | 29,211,899) | 29,351,737) | 27,869,687) | 28,099,671) | 28,094,404) | 26,740,291) | 26,818,165) | 25,751,076) | 25,531,426) | 25,542,758) | ||||||||
| Liquidity Ratio | |||||||||||||||||||||||||||||||||||
| Current ratio1 | 0.88 | 0.89 | 0.91 | 0.91 | 0.92 | 0.92 | 0.95 | 0.94 | 0.94 | 1.07 | 0.99 | 0.98 | 0.98 | 0.97 | 0.95 | 0.95 | 0.95 | 0.95 | 0.94 | 0.93 | 0.94 | 0.94 | 0.95 | 0.91 | 0.92 | 0.92 | 0.90 | ||||||||
| Benchmarks | |||||||||||||||||||||||||||||||||||
| Current Ratio, Competitors2 | |||||||||||||||||||||||||||||||||||
| Abbott Laboratories | 1.74 | 1.64 | 1.68 | 1.63 | 1.86 | 2.01 | 1.85 | 1.85 | 1.83 | 1.79 | 1.75 | 1.72 | 1.70 | 1.57 | 1.43 | 1.44 | 1.54 | 1.68 | 1.58 | — | — | — | — | — | — | — | — | ||||||||
| Cigna Group | 0.73 | 0.73 | 0.72 | 0.73 | 0.73 | 0.83 | 0.81 | 0.83 | 0.70 | 0.72 | 0.76 | 0.77 | 0.79 | 0.83 | 0.76 | 0.74 | 0.61 | 0.65 | 0.64 | — | — | — | — | — | — | — | — | ||||||||
| CVS Health Corp. | 0.86 | 0.86 | 0.92 | 0.94 | 0.94 | 0.91 | 0.88 | 0.88 | 0.94 | 0.95 | 0.93 | 0.91 | 0.95 | 0.98 | 0.99 | 0.94 | 0.92 | 0.95 | 0.95 | — | — | — | — | — | — | — | — | ||||||||
| Elevance Health Inc. | 1.41 | 1.44 | 1.43 | 1.40 | 1.35 | 1.36 | 1.36 | 1.47 | 1.48 | 1.49 | 1.57 | 1.55 | 1.59 | 1.64 | 1.53 | 1.65 | 1.70 | 1.64 | 1.61 | — | — | — | — | — | — | — | — | ||||||||
| Humana Inc. | 1.37 | 1.37 | 1.39 | 1.52 | 1.35 | 1.53 | 1.53 | 1.62 | 1.72 | 1.71 | 1.67 | 1.77 | 1.81 | 1.69 | 1.66 | 1.82 | 1.83 | 1.75 | 1.65 | — | — | — | — | — | — | — | — | ||||||||
| Intuitive Surgical Inc. | 5.31 | 5.22 | 5.26 | 4.40 | 5.10 | 5.36 | 5.22 | 5.08 | 5.58 | 5.99 | 6.71 | 6.86 | 7.04 | 6.38 | 4.96 | 4.53 | 4.64 | 5.04 | 5.44 | — | — | — | — | — | — | — | — | ||||||||
| Medtronic PLC | 1.76 | 1.76 | 1.58 | 1.86 | 2.61 | 2.91 | 2.89 | 2.65 | 2.10 | 2.16 | 1.87 | 2.13 | 2.75 | 2.77 | 2.67 | 2.59 | 2.36 | 2.56 | 2.46 | 2.28 | 2.43 | 2.40 | 1.64 | — | — | — | — | ||||||||
| UnitedHealth Group Inc. | 0.80 | 0.80 | 0.81 | 0.77 | 0.82 | 0.77 | 0.78 | 0.79 | 0.77 | 0.77 | 0.74 | 0.74 | 0.82 | 0.84 | 0.75 | 0.69 | 0.70 | 0.67 | 0.73 | — | — | — | — | — | — | — | — | ||||||||
Based on: 10-Q (reporting date: 2023-06-30), 10-Q (reporting date: 2023-03-31), 10-Q (reporting date: 2022-12-31), 10-K (reporting date: 2022-09-30), 10-Q (reporting date: 2022-06-30), 10-Q (reporting date: 2022-03-31), 10-Q (reporting date: 2021-12-31), 10-K (reporting date: 2021-09-30), 10-Q (reporting date: 2021-06-30), 10-Q (reporting date: 2021-03-31), 10-Q (reporting date: 2020-12-31), 10-K (reporting date: 2020-09-30), 10-Q (reporting date: 2020-06-30), 10-Q (reporting date: 2020-03-31), 10-Q (reporting date: 2019-12-31), 10-K (reporting date: 2019-09-30), 10-Q (reporting date: 2019-06-30), 10-Q (reporting date: 2019-03-31), 10-Q (reporting date: 2018-12-31), 10-K (reporting date: 2018-09-30), 10-Q (reporting date: 2018-06-30), 10-Q (reporting date: 2018-03-31), 10-Q (reporting date: 2017-12-31), 10-K (reporting date: 2017-09-30), 10-Q (reporting date: 2017-06-30), 10-Q (reporting date: 2017-03-31), 10-Q (reporting date: 2016-12-31).
1 Q3 2023 Calculation
Current ratio = Current assets ÷ Current liabilities
= 40,986,584 ÷ 46,783,211 = 0.88
2 Click competitor name to see calculations.
| Liquidity ratio | Description | The company |
|---|---|---|
| Current ratio | A liquidity ratio calculated as current assets divided by current liabilities. | AmerisourceBergen Corp. current ratio deteriorated from Q1 2023 to Q2 2023 and from Q2 2023 to Q3 2023. |
Quick Ratio
AmerisourceBergen Corp., quick ratio calculation (quarterly data)
| Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selected Financial Data (US$ in thousands) | |||||||||||||||||||||||||||||||||||
| Cash and cash equivalents | 1,389,345) | 1,539,406) | 1,692,205) | 3,388,189) | 3,034,233) | 2,960,759) | 3,168,881) | 2,547,142) | 2,553,217) | 6,641,180) | 4,890,918) | 4,597,746) | 3,420,272) | 3,691,938) | 3,232,604) | 3,374,194) | 2,999,559) | 2,875,750) | 2,540,156) | 2,492,516) | 2,388,928) | 2,091,359) | 3,037,747) | 2,435,115) | 1,311,467) | 2,404,433) | 1,791,134) | ||||||||
| Accounts receivable, less allowances for returns and credit losses | 20,796,648) | 19,491,097) | 18,627,397) | 18,452,675) | 18,624,104) | 18,111,080) | 17,146,056) | 18,167,175) | 17,695,170) | 14,134,326) | 14,886,252) | 13,846,301) | 12,548,399) | 14,210,170) | 12,568,816) | 12,386,879) | 11,989,030) | 12,222,271) | 11,979,382) | 11,314,226) | 11,764,614) | 11,265,014) | 10,127,783) | 10,303,324) | 10,553,258) | 9,583,520) | 9,696,200) | ||||||||
| Total quick assets | 22,185,993) | 21,030,503) | 20,319,602) | 21,840,864) | 21,658,337) | 21,071,839) | 20,314,937) | 20,714,317) | 20,248,387) | 20,775,506) | 19,777,170) | 18,444,047) | 15,968,671) | 17,902,108) | 15,801,420) | 15,761,073) | 14,988,589) | 15,098,021) | 14,519,538) | 13,806,742) | 14,153,542) | 13,356,373) | 13,165,530) | 12,738,439) | 11,864,725) | 11,987,953) | 11,487,334) | ||||||||
| Current liabilities | 46,783,211) | 45,071,097) | 44,760,623) | 43,477,955) | 43,154,310) | 42,797,581) | 41,613,605) | 41,358,641) | 39,589,838) | 32,996,446) | 35,044,451) | 33,853,077) | 30,631,571) | 32,111,790) | 30,630,456) | 29,581,294) | 28,788,871) | 29,211,899) | 29,351,737) | 27,869,687) | 28,099,671) | 28,094,404) | 26,740,291) | 26,818,165) | 25,751,076) | 25,531,426) | 25,542,758) | ||||||||
| Liquidity Ratio | |||||||||||||||||||||||||||||||||||
| Quick ratio1 | 0.47 | 0.47 | 0.45 | 0.50 | 0.50 | 0.49 | 0.49 | 0.50 | 0.51 | 0.63 | 0.56 | 0.54 | 0.52 | 0.56 | 0.52 | 0.53 | 0.52 | 0.52 | 0.49 | 0.50 | 0.50 | 0.48 | 0.49 | 0.47 | 0.46 | 0.47 | 0.45 | ||||||||
| Benchmarks | |||||||||||||||||||||||||||||||||||
| Quick Ratio, Competitors2 | |||||||||||||||||||||||||||||||||||
| Abbott Laboratories | 1.04 | 1.00 | 1.07 | 1.06 | 1.22 | 1.33 | 1.21 | 1.28 | 1.25 | 1.19 | 1.16 | 1.14 | 1.01 | 0.93 | 0.83 | 0.88 | 0.93 | 0.98 | 0.94 | — | — | — | — | — | — | — | — | ||||||||
| Cigna Group | 0.61 | 0.61 | 0.59 | 0.58 | 0.61 | 0.52 | 0.48 | 0.48 | 0.58 | 0.59 | 0.64 | 0.66 | 0.46 | 0.50 | 0.42 | 0.41 | 0.51 | 0.53 | 0.53 | — | — | — | — | — | — | — | — | ||||||||
| CVS Health Corp. | 0.60 | 0.59 | 0.61 | 0.62 | 0.64 | 0.62 | 0.54 | 0.55 | 0.59 | 0.58 | 0.54 | 0.53 | 0.58 | 0.63 | 0.60 | 0.52 | 0.52 | 0.54 | 0.55 | — | — | — | — | — | — | — | — | ||||||||
| Elevance Health Inc. | 1.29 | 1.32 | 1.31 | 1.27 | 1.21 | 1.22 | 1.23 | 1.33 | 1.33 | 1.35 | 1.43 | 1.42 | 1.45 | 1.49 | 1.37 | 1.52 | 1.58 | 1.51 | 1.49 | — | — | — | — | — | — | — | — | ||||||||
| Humana Inc. | 1.15 | 1.16 | 1.18 | 1.20 | 1.13 | 1.21 | 1.21 | 1.20 | 1.32 | 1.28 | 1.26 | 1.37 | 1.47 | 1.35 | 1.29 | 1.47 | 1.51 | 1.36 | 1.32 | — | — | — | — | — | — | — | — | ||||||||
| Intuitive Surgical Inc. | 4.44 | 4.36 | 4.30 | 3.56 | 4.19 | 4.49 | 4.40 | 4.34 | 4.66 | 5.12 | 5.76 | 5.96 | 5.93 | 5.40 | 4.00 | 3.75 | 3.80 | 4.15 | 4.53 | — | — | — | — | — | — | — | — | ||||||||
| Medtronic PLC | 1.18 | 1.18 | 1.01 | 1.30 | 1.87 | 2.07 | 2.06 | 1.91 | 1.58 | 1.63 | 1.37 | 1.50 | 2.05 | 2.02 | 1.95 | 1.90 | 1.69 | 1.88 | 1.83 | 1.71 | 1.85 | 1.84 | 1.25 | — | — | — | — | ||||||||
| UnitedHealth Group Inc. | 0.75 | 0.74 | 0.75 | 0.70 | 0.77 | 0.71 | 0.72 | 0.72 | 0.71 | 0.71 | 0.68 | 0.68 | 0.75 | 0.76 | 0.66 | 0.63 | 0.64 | 0.62 | 0.66 | — | — | — | — | — | — | — | — | ||||||||
Based on: 10-Q (reporting date: 2023-06-30), 10-Q (reporting date: 2023-03-31), 10-Q (reporting date: 2022-12-31), 10-K (reporting date: 2022-09-30), 10-Q (reporting date: 2022-06-30), 10-Q (reporting date: 2022-03-31), 10-Q (reporting date: 2021-12-31), 10-K (reporting date: 2021-09-30), 10-Q (reporting date: 2021-06-30), 10-Q (reporting date: 2021-03-31), 10-Q (reporting date: 2020-12-31), 10-K (reporting date: 2020-09-30), 10-Q (reporting date: 2020-06-30), 10-Q (reporting date: 2020-03-31), 10-Q (reporting date: 2019-12-31), 10-K (reporting date: 2019-09-30), 10-Q (reporting date: 2019-06-30), 10-Q (reporting date: 2019-03-31), 10-Q (reporting date: 2018-12-31), 10-K (reporting date: 2018-09-30), 10-Q (reporting date: 2018-06-30), 10-Q (reporting date: 2018-03-31), 10-Q (reporting date: 2017-12-31), 10-K (reporting date: 2017-09-30), 10-Q (reporting date: 2017-06-30), 10-Q (reporting date: 2017-03-31), 10-Q (reporting date: 2016-12-31).
1 Q3 2023 Calculation
Quick ratio = Total quick assets ÷ Current liabilities
= 22,185,993 ÷ 46,783,211 = 0.47
2 Click competitor name to see calculations.
| Liquidity ratio | Description | The company |
|---|---|---|
| Quick ratio | A liquidity ratio calculated as (cash plus short-term marketable investments plus receivables) divided by current liabilities. | AmerisourceBergen Corp. quick ratio improved from Q1 2023 to Q2 2023 and from Q2 2023 to Q3 2023. |
Cash Ratio
AmerisourceBergen Corp., cash ratio calculation (quarterly data)
| Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selected Financial Data (US$ in thousands) | |||||||||||||||||||||||||||||||||||
| Cash and cash equivalents | 1,389,345) | 1,539,406) | 1,692,205) | 3,388,189) | 3,034,233) | 2,960,759) | 3,168,881) | 2,547,142) | 2,553,217) | 6,641,180) | 4,890,918) | 4,597,746) | 3,420,272) | 3,691,938) | 3,232,604) | 3,374,194) | 2,999,559) | 2,875,750) | 2,540,156) | 2,492,516) | 2,388,928) | 2,091,359) | 3,037,747) | 2,435,115) | 1,311,467) | 2,404,433) | 1,791,134) | ||||||||
| Total cash assets | 1,389,345) | 1,539,406) | 1,692,205) | 3,388,189) | 3,034,233) | 2,960,759) | 3,168,881) | 2,547,142) | 2,553,217) | 6,641,180) | 4,890,918) | 4,597,746) | 3,420,272) | 3,691,938) | 3,232,604) | 3,374,194) | 2,999,559) | 2,875,750) | 2,540,156) | 2,492,516) | 2,388,928) | 2,091,359) | 3,037,747) | 2,435,115) | 1,311,467) | 2,404,433) | 1,791,134) | ||||||||
| Current liabilities | 46,783,211) | 45,071,097) | 44,760,623) | 43,477,955) | 43,154,310) | 42,797,581) | 41,613,605) | 41,358,641) | 39,589,838) | 32,996,446) | 35,044,451) | 33,853,077) | 30,631,571) | 32,111,790) | 30,630,456) | 29,581,294) | 28,788,871) | 29,211,899) | 29,351,737) | 27,869,687) | 28,099,671) | 28,094,404) | 26,740,291) | 26,818,165) | 25,751,076) | 25,531,426) | 25,542,758) | ||||||||
| Liquidity Ratio | |||||||||||||||||||||||||||||||||||
| Cash ratio1 | 0.03 | 0.03 | 0.04 | 0.08 | 0.07 | 0.07 | 0.08 | 0.06 | 0.06 | 0.20 | 0.14 | 0.14 | 0.11 | 0.11 | 0.11 | 0.11 | 0.10 | 0.10 | 0.09 | 0.09 | 0.09 | 0.07 | 0.11 | 0.09 | 0.05 | 0.09 | 0.07 | ||||||||
| Benchmarks | |||||||||||||||||||||||||||||||||||
| Cash Ratio, Competitors2 | |||||||||||||||||||||||||||||||||||
| Abbott Laboratories | 0.54 | 0.57 | 0.66 | 0.66 | 0.74 | 0.75 | 0.65 | 0.78 | 0.75 | 0.71 | 0.67 | 0.60 | 0.46 | 0.46 | 0.34 | 0.38 | 0.41 | 0.37 | 0.36 | — | — | — | — | — | — | — | — | ||||||||
| Cigna Group | 0.20 | 0.22 | 0.20 | 0.17 | 0.19 | 0.11 | 0.12 | 0.14 | 0.13 | 0.15 | 0.24 | 0.32 | 0.15 | 0.20 | 0.13 | 0.14 | 0.17 | 0.17 | 0.20 | — | — | — | — | — | — | — | — | ||||||||
| CVS Health Corp. | 0.20 | 0.21 | 0.24 | 0.23 | 0.28 | 0.22 | 0.16 | 0.18 | 0.20 | 0.17 | 0.15 | 0.18 | 0.19 | 0.27 | 0.21 | 0.15 | 0.14 | 0.17 | 0.16 | — | — | — | — | — | — | — | — | ||||||||
| Elevance Health Inc. | 0.90 | 0.92 | 0.91 | 0.86 | 0.87 | 0.86 | 0.86 | 0.95 | 0.97 | 0.97 | 1.08 | 1.04 | 1.04 | 1.10 | 0.95 | 1.08 | 1.14 | 1.07 | 1.04 | — | — | — | — | — | — | — | — | ||||||||
| Humana Inc. | 1.09 | 1.11 | 1.06 | 1.10 | 1.07 | 1.02 | 1.02 | 1.08 | 1.20 | 1.12 | 1.12 | 1.29 | 1.39 | 1.22 | 1.16 | 1.37 | 1.44 | 1.28 | 1.15 | — | — | — | — | — | — | — | — | ||||||||
| Intuitive Surgical Inc. | 3.86 | 3.77 | 3.59 | 2.90 | 3.50 | 3.78 | 3.58 | 3.66 | 3.98 | 4.42 | 5.04 | 5.30 | 5.27 | 4.85 | 3.44 | 3.13 | 3.11 | 3.37 | 3.79 | — | — | — | — | — | — | — | — | ||||||||
| Medtronic PLC | 0.77 | 0.79 | 0.63 | 0.85 | 1.26 | 1.37 | 1.36 | 1.27 | 1.17 | 1.18 | 0.99 | 1.06 | 1.33 | 1.27 | 1.25 | 1.16 | 1.03 | 1.20 | 1.21 | 1.11 | 1.32 | 1.29 | 0.86 | — | — | — | — | ||||||||
| UnitedHealth Group Inc. | 0.42 | 0.44 | 0.43 | 0.36 | 0.46 | 0.36 | 0.37 | 0.36 | 0.35 | 0.35 | 0.33 | 0.33 | 0.37 | 0.42 | 0.35 | 0.28 | 0.30 | 0.32 | 0.32 | — | — | — | — | — | — | — | — | ||||||||
Based on: 10-Q (reporting date: 2023-06-30), 10-Q (reporting date: 2023-03-31), 10-Q (reporting date: 2022-12-31), 10-K (reporting date: 2022-09-30), 10-Q (reporting date: 2022-06-30), 10-Q (reporting date: 2022-03-31), 10-Q (reporting date: 2021-12-31), 10-K (reporting date: 2021-09-30), 10-Q (reporting date: 2021-06-30), 10-Q (reporting date: 2021-03-31), 10-Q (reporting date: 2020-12-31), 10-K (reporting date: 2020-09-30), 10-Q (reporting date: 2020-06-30), 10-Q (reporting date: 2020-03-31), 10-Q (reporting date: 2019-12-31), 10-K (reporting date: 2019-09-30), 10-Q (reporting date: 2019-06-30), 10-Q (reporting date: 2019-03-31), 10-Q (reporting date: 2018-12-31), 10-K (reporting date: 2018-09-30), 10-Q (reporting date: 2018-06-30), 10-Q (reporting date: 2018-03-31), 10-Q (reporting date: 2017-12-31), 10-K (reporting date: 2017-09-30), 10-Q (reporting date: 2017-06-30), 10-Q (reporting date: 2017-03-31), 10-Q (reporting date: 2016-12-31).
1 Q3 2023 Calculation
Cash ratio = Total cash assets ÷ Current liabilities
= 1,389,345 ÷ 46,783,211 = 0.03
2 Click competitor name to see calculations.
| Liquidity ratio | Description | The company |
|---|---|---|
| Cash ratio | A liquidity ratio calculated as (cash plus short-term marketable investments) divided by current liabilities. | AmerisourceBergen Corp. cash ratio deteriorated from Q1 2023 to Q2 2023 and from Q2 2023 to Q3 2023. |